BerandaHNSPF • OTCMKTS
add
Hansoh Pharmaceutical Group Company Ltd
Tutup sebelumnya
$3,45
Rentang tahun
$1,95 - $5,58
Kapitalisasi pasar
138,27Â M HKD
Volume Rata-Rata
50,00
Rasio P/E
-
Hasil dividen
-
Bursa utama
HKG
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (CNY) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 2,88Â M | 2,91% |
Biaya operasional | 1,96Â M | 13,40% |
Laba bersih | 823,15Â jt | -17,22% |
Margin laba bersih | 28,60 | -19,57% |
Penghasilan per saham | — | — |
EBITDA | 739,07Â jt | -18,16% |
Tarif pajak efektif | 16,30% | — |
Neraca
Total aset
Total liabilitas
| (CNY) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 23,39Â M | -6,02% |
Total aset | 31,66Â M | -4,18% |
Total liabilitas | 2,98Â M | -58,89% |
Total ekuitas | 28,68 M | — |
Saham yang beredar | 5,93 M | — |
Harga terhadap nilai buku | 0,71 | — |
Tingkat pengembalian aset | 5,15% | — |
Tingkat pengembalian modal | 5,67% | — |
Arus Kas
Perubahan kas bersih
| (CNY) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 823,15Â jt | -17,22% |
Kas dari operasi | — | — |
Kas dari investasi | — | — |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | — | — |
Arus kas bebas | — | — |
Tentang
Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company that manufactures and sells various types of medicine in mainland China. It was founded in 1995 in Lianyungang, Jiangsu Province, China, by Zhong Huijuan, who is the company's chair. Zhong and her family own 66% of the company. It is the largest psychotropic drug producer in China.
Hansoh Pharmaceutical had an initial public offering on the main board of the Hong Kong Stock Exchange on 14 June 2019.
In August 2022, it was announced that the company's stock would be added to the Hang Seng Index. Wikipedia
Didirikan
1995
Situs
Karyawan
8.989
